Comparing complication rates between Abbott Tendril 2088 and competitive manufacturer leads: Novel real-world data approach.

ABSTRACT:

Introduction

While several studies have reported on the reliability of cardiac pacing leads, there are limited comparative data on lead performance. We compared long-term performance of Abbott Tendril™ STS 2088TC (Tendril 2088) leads with competitive manufacturer (CM) pacing leads using novel real-world data analytic methods.

Methods

Medicare fee-for-service (FFS) claims and Abbott device registration databases were linked to identify patients implanted with single-chamber or dual-chamber pacemakers with the Abbott Tendril 2088 lead from January 1, 2014 to December 31, 2019 and were followed through December 31, 2021. Medicare pacemaker patients who did not link to Abbott devices were assumed to have CM leads. Patients in both groups had to be enrolled in Medicare FFS at lea

SUBMITTER: Ahmed A 

PROVIDER: S-EPMC11650435 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature